Ganaplacide/Lumefantrine

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NameGanaplacide/Lumefantrine
Drug Alias NameGNF-156+lumefantrineKAF-156+lumefantrineKLU156KLU-156
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsProtein synthesis inhibitorsHemozoin inhibitors +[4] 
TargetsHemozoinPhosphatidylinositol 4-kinase
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryZambiaUgandaRwanda +[12] 
CombinationsYes GanaplacideLumefantrine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgMedicines for Malaria Venture
Inactive CompaniesN/A
Active IndicationsMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A